ClinicalTrials.gg

How we know

Every link on this study, and who decided it

The study on the left, the conditions and drugs this site links it to, and on each link the judgments that made or checked it, by day and by judge. The top row is the record itself: each new version seen since tracking began. Dashed lines are links the registry record does not make itself. Select a link to see everything judged on it, or a mark for one decision with its reason and evidence.

5 links3 made here, not in the record5 judgments2 judges (the rules as one: Rule based)1 record change seen
Claude Opus 5.5Rule basedRecord updated on ClinicalTrials.govMade here
Oct 19Oct 26Nov 2Nov 9Nov 16TodayNCT05593094A Phase 1 Trial ofZN-A-1041 Enteric Capsulesor Combination inParticipants With HumanEpidermal Growth FactorReceptor 2 (HER2)-PositiveAdvanced Solid TumorsHoffmann-La RochePhase 1/Phase 2 · active not rRECORDThe record itselfVersions seen nightly since Sep 25, 2…›Nov 19 · ClinicalTrials.gov record · Version of 2026-11-19Version of 2026-11-19CONDITIONSBrain NeoplasmsThe registry's MeSH filing›Nov 14 · Rule based · Finest filed termFinest filed termDRUGSBizrolertinibEntry “ZN-A-1041”, read by our name r…›Nov 18 · Rule based · TestedTestedTrastuzumabMade here · Found by reading; no entr…›Nov 2 · Claude Opus 5.5 · BackgroundBackgroundPertuzumabMade here · Found by reading; no entr…›Nov 3 · Claude Opus 5.5 · BackgroundBackgroundAdo-Trastuzumab EmtansineMade here · Found by reading; no entr…›Nov 10 · Claude Opus 5.5 · Background · partnerBackground · partner

Times are in your time zone; a day marked “day only” kept no time. The graph scrolls sideways on a narrow screen; every mark is also in the list below.

Trastuzumab

Made here1 judgment on this link
NCT05593094gives it, found by reading the recordTrastuzumabDefined by Claude Opus 5.5Nov 2, 2026, 3:40 AM UTC
Role in the study, from the registry to what was judged
RegistryNot in the recordno intervention entry names it
→judged

All judgments on this study

WhenLinkJudgeDecisionState
Nov 2Trastuzumabmade hereClaude Opus 5.5BackgroundCurrent
Nov 3Pertuzumabmade hereClaude Opus 5.5BackgroundCurrent
Nov 10Ado-Trastuzumab Emtansinemade hereClaude Opus 5.5Background · partnerCurrent
Nov 14Brain NeoplasmsRule based · condition-kind ruleFinest filed termCurrent
Nov 18BizrolertinibRule based · role ruleTestedCurrent
Nov 19The record itselfClinicalTrials.gov recordVersion of 2026-11-19Record change

The rules, in plain words

“Rule based” means one of these decided, not a model or a person. Each runs every night over every study.

Which drugs a study tests

Reads each treatment the study lists and the arms it is in. A drug only in the experimental arm is tested. A drug in every arm while something else changes between the arms is given beside it. A drug only in the control arm is the comparator. Placebo, procedures and usual care are known by name.

Where the whole record has been read, that reading's answer replaces the rule's.

How a condition link is counted

For each condition a study is filed under: whether it is the study's own condition at the finest the study states it, a wider one, a general category, or filed by mistake; and whether it is the main condition, a setting the study names, or only how it was filed.

A decision on file for one study overrides it, with who made it and when.